Related references
Note: Only part of the references are listed.Quality control for microarray analysis of human brain samples:: The impact of postmortem factors, RNA characteristics, and histopathology
S. Weis et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2007)
Impact of recent genetic findings in Parkinson's disease
Christine Klein et al.
CURRENT OPINION IN NEUROLOGY (2007)
Expression of α-synuclein mRNA in Parkinson's disease
Spiridon Papapetropoulos et al.
MOVEMENT DISORDERS (2007)
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
David Sulzer
TRENDS IN NEUROSCIENCES (2007)
The ups and downs of α-synuclein mRNA expression
Justus C. Daechsel et al.
MOVEMENT DISORDERS (2007)
Mechanistic aspects of Parkinson's disease:: α-synuclein and the biomembrane
Klaus Beyer
CELL BIOCHEMISTRY AND BIOPHYSICS (2007)
Human postmortem tissue: What quality markers matter?
Ana D. Stan et al.
BRAIN RESEARCH (2006)
Stanley Fahn Lecture 2005:: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered
Heiko Braak et al.
MOVEMENT DISORDERS (2006)
Cellular excitability and the regulation of functional neuronal identity: From gene expression to neuromodulation
David J. Schulz et al.
JOURNAL OF NEUROSCIENCE (2006)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanisms of Parkinson's disease linked to pathological α-synuclein:: New targets for drug discovery
Virginia M. -Y. Lee et al.
NEURON (2006)
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
Alfredo Ramirez et al.
NATURE GENETICS (2006)
Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR
Simone Fleige et al.
BIOTECHNOLOGY LETTERS (2006)
Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease
Katrin Beyer et al.
NEUROREPORT (2006)
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease
Demetrius M. Maraganore et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Combining laser capture microdissection with quantitative real-time PCR: Effects of tissue manipulation on RNA quality and gene expression
Ilan A. Kerman et al.
JOURNAL OF NEUROSCIENCE METHODS (2006)
Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data
Lesley Jones et al.
BMC BIOINFORMATICS (2006)
Genetics of Parkinson disease: paradigm shifts and future prospects
MJ Farrer
NATURE REVIEWS GENETICS (2006)
Clinical heterogeneity of α-synuclein gene duplication in Parkinson's disease
K Nishioka et al.
ANNALS OF NEUROLOGY (2006)
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
A Schroeder et al.
BMC MOLECULAR BIOLOGY (2006)
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients
Ornit Chiba-Falek et al.
MOVEMENT DISORDERS (2006)
alpha-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers
Katrin Beyer
ACTA NEUROPATHOLOGICA (2006)
K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons
B Liss et al.
NATURE NEUROSCIENCE (2005)
α-synuclein cooperates with CSPα in preventing neurodegeneration
S Chandra et al.
CELL (2005)
Gene expression profiling in single cells from the pancreatic islets of Langerhans reveals lognormal distribution of mRNA levels
M Bengtsson et al.
GENOME RESEARCH (2005)
Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum
YJ Qin et al.
NEUROREPORT (2005)
Laser capture microdissection and single-cell RT-PCR without RNA purification
KM Keays et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Pathogenesis of nigral cell death in Parkinson's disease
S Przedborski
PARKINSONISM & RELATED DISORDERS (2005)
Real-time RT-PCR normalisation; strategies and considerations
J Huggett et al.
GENES AND IMMUNITY (2005)
Quantitative real-time RT-PCR - a perspective
SA Bustin et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2005)
Occurrence of neuronal inclusions combined with increased nigral expression of α-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice
F Fornai et al.
BRAIN RESEARCH BULLETIN (2005)
α-synuclein protein levels are increased in alcoholic patients and are linked to craving
D Bönsch et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2005)
Mouse model of multiple system atrophy α-synuclein expression in oligodendrocytes causes glial and neuronal degeneration
I Yazawa et al.
NEURON (2005)
Gene dosage and pathogenesis of Parkinson's disease
JL Eriksen et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Regulation of α-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene
O Chiba-Falek et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces
S Imbeaud et al.
NUCLEIC ACIDS RESEARCH (2005)
Alteration in α-synuclein mRNA expression in Parkinson's disease
AE Kingsbury et al.
MOVEMENT DISORDERS (2004)
Guideline to reference gene selection for quantitative real-time PCR
A Radonic et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
Correlating function and gene expression of individual basal ganglia neurons
B Liss et al.
TRENDS IN NEUROSCIENCES (2004)
Combined histochemical staining, RNA amplification, regional, and single cell cDNA analysis within the hippocampus
SD Ginsberg et al.
LABORATORY INVESTIGATION (2004)
Differential expression of α-synuclein isoforms in dementia with Lewy bodies
K Beyer et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2004)
Double-knockout mice for α- and β-synucleins:: Effect on synaptic functions
S Chandra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Chipping away at the chip bias: RNA degradation in microarray analysis
H Auer et al.
NATURE GENETICS (2003)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
α-synuclein is degraded by both autophagy and the proteasome
JL Webb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Part II:: α-synuclein and its molecular pathophysiological role in neurodegenerative disease
KK Dev et al.
NEUROPHARMACOLOGY (2003)
Single-cell transcriptional analysis of neuronal progenitors
I Tietjen et al.
NEURON (2003)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
W Dauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Improved quantitative real-time RT-PCR for expression profiling of individual cells
B Liss
NUCLEIC ACIDS RESEARCH (2002)
Dopamine-dependent neurotoxicity of α-synuclein:: A mechanism for selective neurodegeneration in Parkinson disease
J Xu et al.
NATURE MEDICINE (2002)
Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription
B Liss et al.
EMBO JOURNAL (2001)
Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease
E Rockenstein et al.
BRAIN RESEARCH (2001)
Effects of ischemia on gene expression
J Huang et al.
JOURNAL OF SURGICAL RESEARCH (2001)
Up-regulation of tyrosine hydroxylase mRNA in a sub-population of A10 dopamine neurons in Parkinson's disease
ZY Tong et al.
MOLECULAR BRAIN RESEARCH (2000)
α-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP
M Vila et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
Share Paper
